You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclin-dependent Kinase 6

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

Recruiting
  • Breast Cancer
  • CT scans
  • DEXA scan
  • Bronx, New York
    Montefiore Medical Center
Jan 6, 2023

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

Not yet recruiting
  • Advanced Breast Cancer
  • +6 more
  • Providence, Rhode Island
    Lifespan Cancer Institute
Feb 1, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

    Recruiting
    • Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
    • No intervention; observational
    • Norcross, Georgia
      Center for Rare Neurological Diseases
    Oct 20, 2022

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      CDKL5 Deficiency Disorder Trial (Ganaxolone, Placebo)

      Not yet recruiting
      • CDKL5 Deficiency Disorder
      • (no location specified)
      Feb 18, 2022

      Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +4 more
      • CDK 4/6 inhibitors
      • Endocrine therapy
      • Helsinki, Finland
      • +11 more
      Sep 19, 2023

      Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

      Active, not recruiting
      Has Results
      • Advanced Breast Cancer
      • Beijing, Beijing, China
      • +6 more
      Jun 23, 2022

      Skin Health and Quality of Life in Patients Receiving

      Not yet recruiting
      • Lung Cancer
      • +7 more
      • EQ-5D-5L questionnaire
      • +2 more
      • Roma, Italy
        Roberto Iacovelli
      May 17, 2023

      Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

      Recruiting
      • Breast Cancer Stage IV
      • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
      • Mansoura, Dakahlia, Egypt
        Oncology center mansoura university
      Jan 1, 2023

      Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

      Recruiting
      • Recurrent Endometrial Carcinoma
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Oct 28, 2021

      Cancer Trial in Boston (CYC065)

      Active, not recruiting
      • Cancer
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Apr 22, 2022

      Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)

      Recruiting
      • Breast Cancer
      • Endocrine Therapy and a CDK 4/6 inhibitor
      • Baltimore, Maryland
        Johns Hopkins University
      Jul 18, 2022

      Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

      Withdrawn
      • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
      • +3 more
      • (no location specified)
      Oct 13, 2021

      Toxicity Data in Advanced Breast Cancer Treated With CDK

      Completed
      • Breast Cancer Stage IV
        • Athens, Greece
          Hellenic Oncology Cooperative Group
        Feb 11, 2021

        Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

        Active, not recruiting
        • Metastatic Breast Cancer
        • Breast Carcinoma
        • Birmingham, Alabama
        • +12 more
        Feb 17, 2022

        Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

        Recruiting
        • Chondrosarcoma
        • +2 more
        • Jacksonville, Florida
        • +3 more
        Apr 4, 2022

        Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +2 more
        • CDK Inhibitor AT7519
        • +3 more
        • Washington, District of Columbia
        • +5 more
        Oct 18, 2022

        Triple Negative Breast Tumors Trial in Poland (Palbociclib, Paclitaxel, Carboplatin)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Wrocław, Dolnośląskie, Poland
        • +5 more
        Oct 4, 2021

        CDKL5 Disorder Trial (Ganaxolone)

        Available
        • CDKL5 Disorder
        • (no location specified)
        Apr 1, 2022

        Breast Cancer Trial (Chidamide+ Fulvestrant)

        Not yet recruiting
        • Breast Cancer
        • Chidamide+ Fulvestrant
        • (no location specified)
        Jan 13, 2022